An analysis of the root causes for opioid-related overdose deaths in the United States.
暂无分享,去创建一个
Wayne Wakeland | Nabarun Dasgupta | Todd Grey | S. Fishman | N. Dasgupta | W. Wakeland | S. Schnoll | L. Webster | S. Passik | J. Peppin | P. Fine | R. Stieg | Christina A Porucznik | Erin M Johnson | Lynn R Webster | Susan Cochella | Keri L Fakata | Perry G Fine | Scott M Fishman | Lewis K Lee | Steven D Passik | John Peppin | Albert Ray | Sidney H Schnoll | Richard L Stieg | C. Porucznik | Erin M. Johnson | T. Grey | K. Fakata | A. Ray | Susan Cochella
[1] L. Taylor,et al. The definition of opioid-related deaths in Australia: implications for surveillance and policy. , 2005, Drug and alcohol review.
[2] D. Nutt,et al. Does alcohol increase the risk of overdose death: the need for a translational approach. , 2008, Addiction.
[3] C. Argoff. Clinical Implications of Opioid Pharmacogenetics , 2010, The Clinical journal of pain.
[4] L. Manchikanti,et al. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. , 2007, Journal of opioid management.
[5] D S Rae,et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.
[6] Andrew A Somogyi,et al. Pharmacogenetics of Opioids , 2007, Clinical pharmacology and therapeutics.
[7] R. Portenoy,et al. Establishing "best practices" for opioid rotation: conclusions of an expert panel. , 2009, Journal of pain and symptom management.
[8] J. Gerberding,et al. Unintentional poisoning deaths--United States, 1999-2004. , 2007, MMWR. Morbidity and mortality weekly report.
[9] T. Buclin,et al. Interindividual Variability of the Clinical Pharmacokinetics of Methadone , 2002, Clinical pharmacokinetics.
[10] K. Furu,et al. Benzodiazepines predict use of opioids--a follow-up study of 17,074 men and women. , 2010, Pain medicine.
[11] K. Wells,et al. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? , 2007, Pain medicine.
[12] Li Hui Chen,et al. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. , 2009, NCHS data brief.
[13] David Wang,et al. Sleep-disordered breathing with chronic opioid use , 2007, Expert opinion on drug safety.
[14] H. Thaler,et al. QTc interval prolongation associated with intravenous methadone , 2003, Pain.
[15] Yongli Xi,et al. Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.
[16] K. Bain,et al. A systematic review of opioid conversion ratios used with methadone for the treatment of pain. , 2008, Pain medicine.
[17] K. Wells,et al. Association between mental health disorders, problem drug use, and regular prescription opioid use. , 2006, Archives of internal medicine.
[18] R. Portenoy,et al. Opioid rotation: the science and the limitations of the equianalgesic dose table. , 2009, Journal of pain and symptom management.
[19] Kent Nakamoto,et al. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. , 2009, The American journal on addictions.
[20] Leonard J Paulozzi,et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.
[21] R. Farney,et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. , 2007, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[22] Yongli Xi,et al. Recent changes in drug poisoning mortality in the United States by urban–rural status and by drug type , 2008, Pharmacoepidemiology and drug safety.
[23] B. Grant,et al. Sleep-disordered breathing and chronic opioid therapy. , 2008, Pain medicine.
[24] F. Baud,et al. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. , 2004, Addiction.